跳至主要内容
临床试验/IRCT20201104049257N1
IRCT20201104049257N1招募中3 期

Evaluation of the effect of rivastigmine on decision making in mild cognitive impairment (MCI) patients by Cambridge Neuropsychological Test Automated Battery (CANTAB)

Tehran University of Medical Sciences0 个研究点目标入组 40 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
40 years 至 no limit(—)
性别
All

入选标准

  • Mild cognitive impairment diagnosis on Functional Assessment Staging Test (FAST)=3
  • Age more than 40
  • Third grade education
  • Mini-mental state examination between 24 to 30

排除标准

  • Psychiatric disorder history
  • Untreated depression
  • Vitamin b12 deficiency
  • Uncontrol hypothyroidism
  • Drug abuse during 6 month ago
  • Seizure history
  • Major neurologic disorder
  • Cholinesterase inhibitor administration during 6 month ago
  • Other disease interfere with decision making
  • Heart block, bradycardia (heart rate<60)
  • Gastrointestinal bleeding during 6 month ago
  • Pregnancy and lactation
  • Rivastigmine allergy

研究者

相似试验